135 related articles for article (PubMed ID: 1806912)
1. [Auxological data and definitive height in short patients without hormonal deficiencies. A longitudinal study].
Tassoni P; Colli C; Paterra RA; Mandini M; Tosi M; Parisi G; Viti A; Cacciari E
Pediatr Med Chir; 1991; 13(6):565-8. PubMed ID: 1806912
[TBL] [Abstract][Full Text] [Related]
2. Auxological outcome and time to menarche following long-acting goserelin therapy in girls with central precocious or early puberty.
Paterson WF; McNeill E; Young D; Donaldson MD
Clin Endocrinol (Oxf); 2004 Nov; 61(5):626-34. PubMed ID: 15521967
[TBL] [Abstract][Full Text] [Related]
3. Constitutional delay of growth: expected versus final adult height.
LaFranchi S; Hanna CE; Mandel SH
Pediatrics; 1991 Jan; 87(1):82-7. PubMed ID: 1984625
[TBL] [Abstract][Full Text] [Related]
4. Adult height in children with growth hormone deficiency who are treated with biosynthetic growth hormone: the National Cooperative Growth Study experience.
August GP; Julius JR; Blethen SL
Pediatrics; 1998 Aug; 102(2 Pt 3):512-6. PubMed ID: 9685455
[TBL] [Abstract][Full Text] [Related]
5. Factors predicting final height in early treated congenital hypothyroid patients.
Delvecchio M; Salerno M; Acquafredda A; Zecchino C; Fico F; Manca F; Faienza MF; Cavallo L
Clin Endocrinol (Oxf); 2006 Nov; 65(5):693-7. PubMed ID: 17054475
[TBL] [Abstract][Full Text] [Related]
6. Short-term therapy with recombinant growth hormone in polytransfused thalassaemia major patients with growth deficiency.
Cavallo L; Gurrado R; Zecchino C; Manolo F; De Sanctis V; Cisternino M; Caruso-Nicoletti M; Galati M
J Pediatr Endocrinol Metab; 1998; 11 Suppl 3():845-9. PubMed ID: 10091155
[TBL] [Abstract][Full Text] [Related]
7. [Precocious puberty, Gh deficiency and obesity can affect final height in patients with myelomeningocele: comparison of males and females].
Galluzzi F; Bindi G; Poggi G; Rossi S; Danti DA; Salti R
Pediatr Med Chir; 1999; 21(2):73-8. PubMed ID: 10570785
[TBL] [Abstract][Full Text] [Related]
8. [The delay of bone maturation is a favorable element in the prognosis of final height].
Rochiccioli P; Tock Mine YY; Enjaume C; Dutau G; Sablayrolles B
Arch Fr Pediatr; 1985 Apr; 42(4):273-6. PubMed ID: 4004488
[TBL] [Abstract][Full Text] [Related]
9. [Accuracy of three methods of height prediction in a group of variant short stature children].
Bueno Lozano G; Ruibal Francisco JL; Reverte Blanc F; Casado de Frías E
An Esp Pediatr; 1998 Jul; 49(1):27-32. PubMed ID: 9718763
[TBL] [Abstract][Full Text] [Related]
10. [Use of arginine hydrochloride in non-endocrine growth disorders].
Saggese G; Cesaretti G; Ghirri P
Minerva Pediatr; 1990 Nov; 42(11):449-59. PubMed ID: 2082171
[TBL] [Abstract][Full Text] [Related]
11. [Impact of gonadotropin-releasing hormone analogs treatment on final height in girls with central precocious puberty].
Chen SK; Fan X; Tang Q
Zhongguo Dang Dai Er Ke Za Zhi; 2009 May; 11(5):374-6. PubMed ID: 19470261
[TBL] [Abstract][Full Text] [Related]
12. [Natural history of intrauterine growth retardation: pubertal growth and adult height].
Job JC; Rolland A
Arch Fr Pediatr; 1986 May; 43(5):301-6. PubMed ID: 3778088
[TBL] [Abstract][Full Text] [Related]
13. Final height of patients treated for isolated GH deficiency: examination of 83 patients.
Cacciari E; Cicognani A; Pirazzoli P; Zucchini S; Salardi S; Balsamo A; Cassio A; Pasini A; Carlá G; Tassinari D; Gualandi S
Eur J Endocrinol; 1997 Jul; 137(1):53-60. PubMed ID: 9242202
[TBL] [Abstract][Full Text] [Related]
14. [The treatment with biosynthetic growth hormone (GH) of familial short stature].
Farello G; De Simone M; Gentile T; De Matteis F
Minerva Pediatr; 1994; 46(7-8):347-50. PubMed ID: 7935253
[TBL] [Abstract][Full Text] [Related]
15. Analysis of linear growth during puberty.
Tanaka T; Suwa S; Yokoya S; Hibi I
Acta Paediatr Scand Suppl; 1988; 347():25-9. PubMed ID: 3254033
[TBL] [Abstract][Full Text] [Related]
16. Are short boys with constitutional delay of growth and puberty candidates for rGH therapy according to FDA recommendations?
Krajewska-Siuda E; Malecka-Tendera E; Krajewski-Siuda K
Horm Res; 2006; 65(4):192-6. PubMed ID: 16549932
[TBL] [Abstract][Full Text] [Related]
17. Overestimation of final height prediction in patients with classical congenital adrenal hyperplasia using the Bayley and Pinneau method.
Bonfig W; Schwarz HP
J Pediatr Endocrinol Metab; 2012; 25(7-8):645-9. PubMed ID: 23155688
[TBL] [Abstract][Full Text] [Related]
18. Gonadotropin-releasing hormone agonist treatment of girls with constitutional short stature and normal pubertal development.
Carel JC; Hay F; Coutant R; Rodrigue D; Chaussain JL
J Clin Endocrinol Metab; 1996 Sep; 81(9):3318-22. PubMed ID: 8784090
[TBL] [Abstract][Full Text] [Related]
19. No difference in pubertal growth and final height between treated hypogonadal and non-hypogonadal thalassemic patients.
Caruso-Nicoletti M; De Sanctis V; Raiola G; Skordis N; Mancuso M; Coco M; Wonke B
Horm Res; 2004; 62(1):17-22. PubMed ID: 15073434
[TBL] [Abstract][Full Text] [Related]
20. The validity of the Bayley-Pinneau method in predicting final adult height at the onset of puberty in patients with classic congenital adrenal hyperplasia.
Badawi N; Fawaz L; Amin A; Kamel A; Arafa N
Endokrynol Pol; 2021; 72(4):301-307. PubMed ID: 34010438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
